Carolina immunologist Nilu Goonetilleke received a $5.6 million grant from the NIH to study therapeutics that may strengthen the immune system's response to HIV. The ultimate goal is to identify optimal strategies to find a cure for people living with HIV.
The UNC Eshelman School of Pharmacy, along with school alumni in the field, are taking steps now to prepare for the possibility of vaccinating the general public.
This partnership will expand the recently approved relationship between these two organizations in New Hanover County to include Mecklenburg, Forsyth and other counties, with an additional focus to find innovative solutions to enhance care in rural areas.
The medical director of the HIV Cure Center is leading a clinical research team in the UNC Division of Infectious Diseases to conduct a large phase 3 trial for a COVID-19 vaccine.